AstraZeneca AB et al v. Macleods Pharmaceuticals Ltd. et al
| AstraZeneca Pharmaceuticals LP and AstraZeneca AB |
| Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. |
| 1:2020cv01180 |
| September 3, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 26, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: #1 Consent Judgment)(nms) |
| Filing 12 CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 10/26/2020. (nms) |
| Filing 11 PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 10/26/2020 (nms). |
Filing 10
ORAL ORDER: An answer was due to be filed on 10/15/2020 (see D.I. #9 ), and to date none has been filed. Now the Plaintiff shall file a status letter within 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 10/23/2020. (nms)
|
| Filing 9 SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Macleods Pharma USA, Inc. served on 9/24/2020, answer due 10/15/2020. (Joyce, Alexandra) |
| Filing 8 DECLARATION of Service of Defendant Macleods Pharmaceuticals Ltd. made on September 24, 2020, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibits A-B)(Joyce, Alexandra) Modified on 10/2/2020 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 7 Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 7/22/2020. Date of Expiration of Patent: 1/27/2036.Thirty Month Stay Deadline: No earlier than 1/23/2023. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3176751.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
